HEADER MEMBRANE PROTEIN 06-DEC-21 7T32
TITLE CRYOEM STRUCTURE OF THE ADENOSINE 2A RECEPTOR-BRIL/ANTI BRIL FAB
TITLE 2 COMPLEX WITH ZM241385
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: ADENOSINE RECEPTOR A2A/SOLUBLE CYTOCHROME B562 FUSION
COMPND 3 PROTEIN;
COMPND 4 CHAIN: A;
COMPND 5 SYNONYM: CYTOCHROME B-562;
COMPND 6 ENGINEERED: YES;
COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606, 562;
SOURCE 5 GENE: ADORA2A, ADORA2, CYBC;
SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606
KEYWDS A2AAR, GPCR, ADENOSINE RECEPTOR, MEMBRANE PROTEIN
EXPDTA ELECTRON MICROSCOPY
AUTHOR K.H.ZHANG,H.WU,N.HOPPE,A.MANGLIK,Y.F.CHENG
REVDAT 2 16-OCT-24 7T32 1 REMARK
REVDAT 1 10-AUG-22 7T32 0
JRNL AUTH K.ZHANG,H.WU,N.HOPPE,A.MANGLIK,Y.CHENG
JRNL TITL FUSION PROTEIN STRATEGIES FOR CRYO-EM STUDY OF G
JRNL TITL 2 PROTEIN-COUPLED RECEPTORS.
JRNL REF NAT COMMUN V. 13 4366 2022
JRNL REFN ESSN 2041-1723
JRNL PMID 35902590
JRNL DOI 10.1038/S41467-022-32125-2
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH W.LIU
REMARK 1 TITL STRUCTURAL BASIS FOR ALLOSTERIC REGULATION OF GPCRS BY
REMARK 1 TITL 2 SODIUM IONS
REMARK 1 REF SCIENCE V. 337 232 2012
REMARK 1 REFN ISSN 0036-8075
REMARK 1 DOI 10.1126/SCIENCE.1219218
REMARK 2
REMARK 2 RESOLUTION. 3.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 SOFTWARE PACKAGES : NULL
REMARK 3 RECONSTRUCTION SCHEMA : NULL
REMARK 3
REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT
REMARK 3 PDB ENTRY : NULL
REMARK 3 REFINEMENT SPACE : NULL
REMARK 3 REFINEMENT PROTOCOL : NULL
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL
REMARK 3
REMARK 3 FITTING PROCEDURE : NULL
REMARK 3
REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS
REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.400
REMARK 3 NUMBER OF PARTICLES : 215946
REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE
REMARK 3 CORRECTION
REMARK 3
REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL
REMARK 3
REMARK 3 OTHER DETAILS: NULL
REMARK 4
REMARK 4 7T32 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-21.
REMARK 100 THE DEPOSITION ID IS D_1000261579.
REMARK 245
REMARK 245 EXPERIMENTAL DETAILS
REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE
REMARK 245 SPECIMEN TYPE : NULL
REMARK 245
REMARK 245 ELECTRON MICROSCOPE SAMPLE
REMARK 245 SAMPLE TYPE : CELL
REMARK 245 PARTICLE TYPE : POINT
REMARK 245 NAME OF SAMPLE : A2A ADENOSINE RECEPTOR
REMARK 245 -BRIL/ANTI BRIL FAB COMPLEX
REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL
REMARK 245 SAMPLE SUPPORT DETAILS : NULL
REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL
REMARK 245 SAMPLE BUFFER : NULL
REMARK 245 PH : 7.50
REMARK 245 SAMPLE DETAILS : NULL
REMARK 245
REMARK 245 DATA ACQUISITION
REMARK 245 DATE OF EXPERIMENT : NULL
REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL
REMARK 245 TEMPERATURE (KELVIN) : NULL
REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS
REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K)
REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00
REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00
REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 NOMINAL CS : NULL
REMARK 245 IMAGING MODE : BRIGHT FIELD
REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6700.00
REMARK 245 ILLUMINATION MODE : SPOT SCAN
REMARK 245 NOMINAL MAGNIFICATION : NULL
REMARK 245 CALIBRATED MAGNIFICATION : NULL
REMARK 245 SOURCE : FIELD EMISSION GUN
REMARK 245 ACCELERATION VOLTAGE (KV) : 300
REMARK 245 IMAGING DETAILS : NULL
REMARK 247
REMARK 247 ELECTRON MICROSCOPY
REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON
REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE
REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES
REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION
REMARK 247 OF THE STRUCTURE FACTORS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ALA A 251
REMARK 465 THR A 252
REMARK 465 PRO A 253
REMARK 465 PRO A 254
REMARK 465 LYS A 255
REMARK 465 LEU A 256
REMARK 465 GLU A 257
REMARK 465 ASP A 258
REMARK 465 LYS A 259
REMARK 465 SER A 260
REMARK 465 PRO A 261
REMARK 465 ASP A 262
REMARK 465 SER A 263
REMARK 465 PRO A 264
REMARK 465 GLU A 265
REMARK 465 MET A 266
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ILE A 10 CG1 CG2 CD1
REMARK 470 LEU A 37 CG CD1 CD2
REMARK 470 ASP A 52 CG OD1 OD2
REMARK 470 CYS A 82 SG
REMARK 470 ARG A 107 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 111 NE CZ NH1 NH2
REMARK 470 LYS A 122 CD CE NZ
REMARK 470 GLN A 148 CG CD OE1 NE2
REMARK 470 LYS A 153 CG CD CE NZ
REMARK 470 GLU A 161 CG CD OE1 OE2
REMARK 470 ARG A 199 NE CZ NH1 NH2
REMARK 470 ARG A 206 CG CD NE CZ NH1 NH2
REMARK 470 ASP A 210 CG OD1 OD2
REMARK 470 LYS A 223 CG CD CE NZ
REMARK 470 LYS A 227 CG CD CE NZ
REMARK 470 LYS A 240 CG CD CE NZ
REMARK 470 PHE A 269 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 HIS A 271 CG ND1 CD2 CE1 NE2
REMARK 470 GLU A 315 CG CD OE1 OE2
REMARK 470 ARG A 316 CD NE CZ NH1 NH2
REMARK 470 ARG A 318 NE CZ NH1 NH2
REMARK 470 LYS A 323 CD CE NZ
REMARK 470 LYS A 329 CG CD CE NZ
REMARK 470 ASP A 357 CG OD1 OD2
REMARK 470 ARG A 389 CZ NH1 NH2
REMARK 470 GLU A 390 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 72 -167.77 -161.55
REMARK 500 VAL A 186 -62.27 -97.17
REMARK 500 ASP A 229 -166.08 -161.08
REMARK 500 ASN A 230 56.24 29.82
REMARK 500 ALA A 231 -108.87 36.34
REMARK 500 ALA A 232 -67.91 22.95
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: EMD-25648 RELATED DB: EMDB
REMARK 900 CRYOEM STUCTURE OF THE ADENOSINE 2A RECEPTOR-BRIL/ANTI BRIL FAB
REMARK 900 COMPLEX WITH ZM241385
DBREF 7T32 A 8 208 UNP P29274 AA2AR_HUMAN 8 208
DBREF 7T32 A 209 314 UNP P0ABE7 C562_ECOLX 23 128
DBREF 7T32 A 315 398 UNP P29274 AA2AR_HUMAN 219 302
SEQADV 7T32 TRP A 215 UNP P0ABE7 MET 29 CONFLICT
SEQADV 7T32 ILE A 310 UNP P0ABE7 HIS 124 CONFLICT
SEQADV 7T32 LEU A 314 UNP P0ABE7 ARG 128 CONFLICT
SEQRES 1 A 391 VAL TYR ILE THR VAL GLU LEU ALA ILE ALA VAL LEU ALA
SEQRES 2 A 391 ILE LEU GLY ASN VAL LEU VAL CYS TRP ALA VAL TRP LEU
SEQRES 3 A 391 ASN SER ASN LEU GLN ASN VAL THR ASN TYR PHE VAL VAL
SEQRES 4 A 391 SER LEU ALA ALA ALA ASP ILE ALA VAL GLY VAL LEU ALA
SEQRES 5 A 391 ILE PRO PHE ALA ILE THR ILE SER THR GLY PHE CYS ALA
SEQRES 6 A 391 ALA CYS HIS GLY CYS LEU PHE ILE ALA CYS PHE VAL LEU
SEQRES 7 A 391 VAL LEU THR GLN SER SER ILE PHE SER LEU LEU ALA ILE
SEQRES 8 A 391 ALA ILE ASP ARG TYR ILE ALA ILE ARG ILE PRO LEU ARG
SEQRES 9 A 391 TYR ASN GLY LEU VAL THR GLY THR ARG ALA LYS GLY ILE
SEQRES 10 A 391 ILE ALA ILE CYS TRP VAL LEU SER PHE ALA ILE GLY LEU
SEQRES 11 A 391 THR PRO MET LEU GLY TRP ASN ASN CYS GLY GLN PRO LYS
SEQRES 12 A 391 GLU GLY LYS ASN HIS SER GLN GLY CYS GLY GLU GLY GLN
SEQRES 13 A 391 VAL ALA CYS LEU PHE GLU ASP VAL VAL PRO MET ASN TYR
SEQRES 14 A 391 MET VAL TYR PHE ASN PHE PHE ALA CYS VAL LEU VAL PRO
SEQRES 15 A 391 LEU LEU LEU MET LEU GLY VAL TYR LEU ARG ILE PHE LEU
SEQRES 16 A 391 ALA ALA ARG ARG GLN LEU ALA ASP LEU GLU ASP ASN TRP
SEQRES 17 A 391 GLU THR LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA
SEQRES 18 A 391 ASP ASN ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET
SEQRES 19 A 391 ARG ALA ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO
SEQRES 20 A 391 LYS LEU GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS
SEQRES 21 A 391 ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE
SEQRES 22 A 391 ASP ASP ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS
SEQRES 23 A 391 GLU ALA GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG
SEQRES 24 A 391 ASN ALA TYR ILE GLN LYS TYR LEU GLU ARG ALA ARG SER
SEQRES 25 A 391 THR LEU GLN LYS GLU VAL HIS ALA ALA LYS SER LEU ALA
SEQRES 26 A 391 ILE ILE VAL GLY LEU PHE ALA LEU CYS TRP LEU PRO LEU
SEQRES 27 A 391 HIS ILE ILE ASN CYS PHE THR PHE PHE CYS PRO ASP CYS
SEQRES 28 A 391 SER HIS ALA PRO LEU TRP LEU MET TYR LEU ALA ILE VAL
SEQRES 29 A 391 LEU SER HIS THR ASN SER VAL VAL ASN PRO PHE ILE TYR
SEQRES 30 A 391 ALA TYR ARG ILE ARG GLU PHE ARG GLN THR PHE ARG LYS
SEQRES 31 A 391 ILE
HET ZMA A1201 25
HETNAM ZMA 4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,
HETNAM 2 ZMA 5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL
FORMUL 2 ZMA C16 H15 N7 O2
HELIX 1 AA1 VAL A 8 LEU A 33 1 26
HELIX 2 AA2 ASN A 39 GLY A 69 1 31
HELIX 3 AA3 ALA A 73 ILE A 108 1 36
HELIX 4 AA4 ILE A 108 VAL A 116 1 9
HELIX 5 AA5 THR A 117 GLY A 142 1 26
HELIX 6 AA6 LYS A 150 GLN A 157 1 8
HELIX 7 AA7 LEU A 167 VAL A 172 1 6
HELIX 8 AA8 PRO A 173 ASN A 181 1 9
HELIX 9 AA9 PHE A 182 LYS A 227 1 46
HELIX 10 AB1 ALA A 232 LYS A 250 1 19
HELIX 11 AB2 ASP A 268 GLU A 289 1 22
HELIX 12 AB3 LYS A 291 CYS A 355 1 65
HELIX 13 AB4 PRO A 362 ARG A 387 1 26
HELIX 14 AB5 ILE A 388 ILE A 398 1 11
SSBOND 1 CYS A 74 CYS A 146 1555 1555 2.03
SSBOND 2 CYS A 77 CYS A 166 1555 1555 2.03
SSBOND 3 CYS A 355 CYS A 358 1555 1555 2.03
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000